Administration of a new diabetes-specific enteral formula results in an improved 24 h glucose profile in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 84, Issue 3, 2009, Pages 259-266

  Ceriello, Antonio ^a   Lansink, Mirian ^b   Rouws, Carlette H F C ^b   van Laere, Katrien M J ^b   Frost, Gary S ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b DANONE RESEARCH   (Netherlands)

^c Div Investigative Sci Imp C   (United Kingdom)

Author keywords

24 h glucose profile; Diabetes mellitus; Enteral nutrition; Postprandial glucose

Indexed keywords

CARBOHYDRATE; FAT; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA;

AGED; ARTICLE; BLOOD SAMPLING; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC DIET; DIABETIC PATIENT; DIARRHEA; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; FEMALE; FIBER; FLATULENCE; FOOD COMPOSITION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SYNCOPE;

AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; ENTERAL NUTRITION; FEMALE; GLUCAGON; GLYCEMIC INDEX; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MONITORING, AMBULATORY; NUTRITIVE VALUE; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 67349262633     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.02.013     Document Type: Article

References (49)

1. American Diabetes Association, Standards of Medical Care in Diabetes-2007. Diabetes Care 30 (2007) S4-S41.
2. Holman R.R., Thorne K.I., Farmer A.J., Davies M.J., Keenan J.F., Paul S., et al. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N. Engl. J. Med. 357 (2007) 1716-1730
3. Woerle H.J., Neumann C., Zschau S., Tenner S., Irsigler A., Schirra J., et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res. Clin. Pract. 77 (2007) 280-285
4. Heine R.J., Balkau B., Ceriello A., Del Prato S., Horton E.S., and Taskinen M.R. What does postprandial hyperglycaemia mean?. Diabet Med. 21 (2004) 208-213
5. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat?. Diabetes 54 (2005) 1-7
6. International Diabetes Federation: Guideline for management of postmeal glucose, 2007, pp. 1-27.
7. Praet S.F., Manders R.J., Meex R.C., Lieverse A.G., Stehouwer C.D., Kuipers H., et al. Glycaemic instability is an underestimated problem in Type II diabetes. Clin. Sci. (Lond.) 111 (2006) 119-126
8. Dickinson S., and Brand-Miller J. Glycemic index, postprandial glycemia and cardiovascular disease. Curr. Opin. Lipidol. 16 (2005) 69-75
9. Barclay A.W., Petocz P., McMillan-Price J., Flood V.M., Prvan T., Mitchell P., et al. Glycemic index, glycemic load, and chronic disease risk-a meta-analysis of observational studies. Am. J. Clin. Nutr. 87 (2008) 627-637
10. Elia M., Ceriello A., Laube H., Sinclair A.J., Engfer M., and Stratton R.J. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: a systematic review and meta-analysis. Diabetes Care 28 (2005) 2267-2279
11. Printz H., Recke B., Fehmann H.C., and Goke B. No apparent benefit of liquid formula diet in NIDDM. Exp. Clin. Endocrinol. Diabetes 105 (1997) 134-139
12. Sanz-Paris A., Calvo L., Guallard A., Salazar I., and Albero R. High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea. Nutrition 14 (1998) 840-845
13. Hofman Z., van Drunen J.D., de Later C., and Kuipers H. The effect of different nutritional feeds on the postprandial glucose response in healthy volunteers and patients with type II diabetes. Eur. J. Clin. Nutr. 58 (2004) 1553-1556
14. McCargar L.J., Innis S.M., Bowron E., Leichter J., Dawson K., Toth E., et al. Effect of enteral nutritional products differing in carbohydrate and fat on indices of carbohydrate and lipid metabolism in patients with NIDDM. Mol. Cell. Biochem. 188 (1998) 81-89
15. Mann J.I., De Leeuw I., Hermansen K., Karamanos B., Karlstrom B., Katsilambros N., et al. Evidence-based nutritional approaches to the treatment and prevention of diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 14 (2004) 373-394
16. Nutrition Recommendations and Interventions for Diabetes: A position statement of the American Diabetes Association, Diabetes Care 30 (Suppl. 1) (2007) S48-S65.
17. Allison D.B., Paultre F., Maggio C., Mezzitis N., and Pi-Sunyer F.X. The use of areas under curves in diabetes research. Diabetes Care 18 (1995) 245-250
18. Altman D.G. Section 15.4.10. Practical Statistics for Medical (1991), Research Chapmann and Hall, London
19. Magnoni D., Rouws C.H., Lansink M., van Laere K.M., and Campos A.C. Long-term use of a diabetes-specific oral nutritional supplement results in a low-postprandial glucose response in diabetes patients. Diabetes Res. Clin. Pract. 80 (2008) 75-82
20. Monnier L., Lapinski H., and Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26 (2003) 881-885
21. Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J. Am. Coll. Cardiol. 34 (1999) 146-154
22. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
23. Decode S.G. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2 h diagnostic criteria. Arch. Intern. Med. 161 (2001) 397-405
24. Nakagami T., Qiao Q., Tuomilehto J., Balkau B., Tajima N., Hu G., et al. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur. J. Cardiovasc. Prev. Rehabil. 13 (2006) 555-561
25. Guvener M., Pasaoglu I., Demircin M., and Oc M. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr. J. 49 (2002) 531-537
26. Pomposelli J.J., Baxter III J.K., BabineauF T.J., Pomfret E.A., Driscoll D.F., Forse R.A., et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. J. Parenter. Enteral. Nutr. 22 (1998) 77-81
27. Greenhalgh D.G. Wound healing and diabetes mellitus. Clin. Plast. Surg. 30 (2003) 37-45
28. Rosenberg C.S. Wound healing in the patient with diabetes mellitus. Nurs. Clin. North Am. 25 (1990) 247-261
29. Umpierrez G.E., Isaacs S.D., Bazargan N., You X., Thaler L.M., and Kitabchi A.E. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J. Clin. Endocrinol. Metab. 87 (2002) 978-982
30. Williams L.S., Rotich J., Qi R., Fineberg N., Espay A., Bruno A., et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 59 (2002) 67-71
31. Krinsley J.S. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin. Proc. 78 (2003) 1471-1478
32. Craig L.D., Nicholson S., SilVerstone F.A., and Kennedy R.D. Use of a reduced-carbohydrate, modified-fat enteral formula for improving metabolic control and clinical outcomes in long-term care residents with type 2 diabetes: results of a pilot trial. Nutrition 14 (1998) 529-534
33. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal. Biochem. 7 (1964) 18-25
34. Grupp U., and Siebert G. Metabolism of hydrogenated palatinose, an equimolar mixture of alpha-d-glucopyranosido-1,6-sorbitol and alpha-d-glucopyranosido-1,6-mannitol. Res. Exp. Med. (Berl.) 173 (1978) 261-278
35. Kawai K., Okuda Y., and Yamashita K. Changes in blood glucose and insulin after an oral palatinose administration in normal subjects. Endocrinol. Jpn. 32 (1985) 933-936
36. Kawai K., Yoshikawa H., Murayama Y., Okuda Y., and Yamashita K. Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm. Metab. Res. 21 (1989) 338-340
37. MacDonald I. The bio-availability of isomaltulose in man and rat. Nutr. Rep. Int. 28 (1983) 1083-1090
38. Liao Z.-H., Li Y.-B., Yao B., Fan H.-D., Hu G.-L., and Weng J.-P. The effect of isomaltulose on blood glucose and lipids for diabetic subjects. Diabetes 50 (2001) A366
39. Severijnen C., Abrahamse E., van der Beek E.M., Buco A., van de Heijning B.J., van Laere K., et al. Sterilization in a liquid of a specific starch makes it slowly digestible in vitro and low glycemic in rats. J. Nutr. 137 (2007) 2202-2207
40. Gannon M.C., Nuttall F.Q., Lane J.T., and Burmeister L.A. Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects. Metabolism 41 (1992) 1137-1145
41. Gannon M.C., Nuttall F.Q., Neil B.J., and Westphal S.A. The insulin and glucose responses to meals of glucose plus various proteins in type II diabetic subjects. Metabolism 37 (1988) 1081-1088
42. Frid A.H., Nilsson M., Holst J.J., and Bjorck I.M. Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am. J. Clin. Nutr. 82 (2005) 69-75
43. Nuttall F.Q., Mooradian A.D., Gannon M.C., Billington C., and Krezowski P. Effect of protein ingestion on the glucose and insulin response to a standardized oral glucose load. Diabetes Care 7 (1984) 465-470
44. Manders R.J., Wagenmakers A.J., Koopman R., Zorenc A.H., Menheere P.P., Schaper N.C., et al. Co-ingestion of a protein hydrolysate and amino acid mixture with carbohydrate improves plasma glucose disposal in patients with type 2 diabetes. Am. J. Clin. Nutr. 82 (2005) 76-83
45. Tessari P., Kiwanuka E., Cristini M., Zaramella M., Enslen M., Zurlo C., et al. Slow versus fast proteins in the stimulation of beta-cell response and the activation of the entero-insular axis in type 2 diabetes. Diabetes Metab. Res. Rev. 23 (2007) 378-385
46. Nilsson M., Stenberg M., Frid A.H., Holst J.J., and Bjorck I.M. Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am. J. Clin. Nutr. 80 (2004) 1246-1253
47. Severijnen C., van der Beek E.M., Hageman R., van Laere K., and van de Heijning B. Amelioration of fasting plasma glucose levels in diabetic rats after two weeks on an aspartate-rich diet. 25th International Symposium on Diabetes and Nutrition (DNSG) (2007)
48. Karamanlis A., Chaikomin R., Doran S., Bellon M., Bartholomeusz F.D., Wishart J.M., et al. Effects of protein on glycemic and incretin responses and gastric emptying after oral glucose in healthy subjects. Am. J. Clin. Nutr. 86 (2007) 1364-1368
49. Monnier L., Colette C., Dunseath G.J., and Owens D.R. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 30 (2007) 263-269